# National GMA Post-market Clinical Follow-up Study (GRACE)

> **NCT05636709** · — · RECRUITING · sponsor: **Adacyte Therapeutics SL** · enrollment: 350 (estimated)

## Conditions studied

- Crohn Disease
- Ulcerative Colitis

## Interventions

- **DEVICE:** Adacolumn

## Key facts

- **NCT ID:** NCT05636709
- **Lead sponsor:** Adacyte Therapeutics SL
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2022-01-11
- **Primary completion:** 2026-06-30
- **Final completion:** 2026-06-30
- **Target enrollment:** 350 (ESTIMATED)
- **Last updated:** 2025-01-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05636709

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05636709, "National GMA Post-market Clinical Follow-up Study (GRACE)". Retrieved via AI Analytics 2026-07-02 from https://api.ai-analytics.org/clinical/NCT05636709. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*